Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.
Cromer I don't recall you ever having openly stated you were shorting.... You did eventually give us a coherent and structured argument with reference to the commercial position of AVO, however this was after you failed miserably with stupid comparisons. If you had come out and said... "I reckon this will all fail and thats why im shorting" I would have a bit more respect for being honest. But you tried to spread investor uncertainty based on your back of a fag packet technological analysis. And No I don't have the time to trawl through your threads... I'm generally too busy doing something constructive with my life.
I believe the testing is on course, and I think we will see this outlined in March. Of course the new financing is not ideal. There are a lot of talented people on board with this. Its not a question of if, but a question of when. Of course the sharks are inpatient for a pay day.
Meldrew I think you might be referring to Plasma wake field acceleration... this indeed has the potential for huge accelerating gradients... but this technology is only in its infancy... basic principles are there but it needs to be further studied and then packaging this into something commercial is another leap of technology... I would estimate we are 20 years away from this... maybe even further.
Indeed Meldrew it is not a circular machine, its a linear machine with a high frequency RFQ (750MHz) with a high accelerating gradient it is this which helps to reduce the size of the machine and there is nothing like to this currently on the particle therapy market.
Looking at the building layout of Harley street, that installation is quite special in terms of the configuration of the beam transfer lines, it will not be as easy as using a blank canvas. I think Pebble Mill will be an easier installation. The technology is sound, the only question is can they keep the faith of the financiers long enough to get a system tested, meet regulatory compliance, installed and treating patients. If they do then, the orders will fly.
Don't get too carried away with Proton therapy being mentioned on Emmerdale, we need a tested system and a commercial version with associated control systems and software and treatment planning software. Once we have this then we are in the Proton Therapy game! I am confident that all of the above will come to fruition in due course.
With Professor Myres on board and his experience with the LHC Medical Applications at CERN, this guy has a huge reputation in this field. I can see SP gains once successful testing regime has been completed and announced, further increases in the SP price to come once production at Thales begins. Of course financing needs to be sought, however these official appointments are very positive.
.. Not really David, I just object to folk who compare apples to pears and then say that one of them is an inferior or pointless option. Varian Medical also have a super conducting cyclotron which as far as i have seen has not been mentioned or covered... which to me is indicative of the poor quality of the market research by certain posters on this board. Moreover is it actually realistic to analyse the technology/product of all your investments in much a manner... I mean do Apple shareholders research and post messages regarding the microelectronics or the LCD screen technology used in Apple products? I am not being facetious in any way just posing a question... maybe its not so applicable to Apple because they are well established, but you catch my drift. I do however agree that that graphic of a gantry compared to a school bus look a rather mickey mouse and needs to be changed to something a bit more representative.
... I don't have the time for this folly Cromer... Please stop posting mixed up data and facts trying to undermine the efforts of company whose technology some of us may indeed relay on to save our lives. Of course it's good to have different views and opinions and by all means express them but do so with facts, when you start pulling random stuff from the internet and making silly comparisons If you want to do some useful research, I suggest you read some radiobiology, electrical engineering and accelerator physics... I can even recommend some titles if you like.
The link you provided https://www.oncologysystems.com/radiation-therapy/linear-accelerators/linear-accelerator-vault-dimensions.php. Show recommended vault sizes for low energy linacs, not super conducting cyclotrons, also these vault sizes don't take into account the shielding requirements. Yet more confused data from Cromer... who is workring on the the policy of BS baffles brains.... not here pal... move on.
Cromer.. Then why don't Harley street buy an installation from a competitor... That Chinese paper is nothing like the LIGHT system, the RFQ is not the same specification for a start, it uses a synchrotron and it's larger... You clearly have very little understanding of the technology or the industry. I am well positioned to speak with confidence on the subject, I know and work in the industry and have much better understanding of the technology than any other commentators here. You clearly don't support AVO's aims all your post's seem to be aimed at undermining the company obviously in an attempt to diminish the share price that i suspect you may be shorting.... Fortunately many here have seen through your BS, you never worried me with your doomsayer tripe because unlike you I understand very well the engineering and technology, the fact you push forward the Chinese paper as some sort of competition demonstrates your a BS'er
You couldn't be any further from the truth, I like most people have been touched by cancer either directly or through a loved one. I want to see more treatment options available for more people than what is currently available. AVO's LIGHT technology provides this hope. I also speak from a position of experience having spent nearly my whole career in medical technology and healthcare sector, I know this sector and these technologies, having first hand worked experience of conventional radiotherapy treatment technologies. I write these posts based on my own experience, education and insight in order to correct some misconceptions or well intentioned errors that have been recently posted here by well intention but albiet laymen. I find your comments quite sad, in the sense that your suspicion of my posts. As though my words my alter the fortunes of AVO through persuading/influencing the actions of the half dozen or so investors/spectators posting in this thread... It is interesting that when someone makes a logical and technically accurate contribution you try and shoot it down, maybe you have your own hidden agenda on this one... but I won't try and pass judgement on your charcter like your did.
There's a few cherry picked quotes here. The reason Proton therapy facilities in the UK are seldom is due to the cost of the current technology including the architectural work required to accommodate these systems, typically Super conducting cyclotrons and the beam transfer lines which deliver the beam to the treatment rooms. The LIGHT system and its very high gradient RFQ (higher specification of that detailed in the Chinese paper) will significantly reduce the physical footprint of the hardware, there is no chance the current technology could be installed into a Harley Street Clinic otherwise it would have been done already. The LIGHT system will reduce the capital costs of providing proton therapy and I believe as a result we will see the near disappearance of Xray therapy, there will still be a place for electron therapy as is currently the case, however the dose distributions with Proton beams is much more favourable to tissues and organs surrounding the target tumour, thus reducing the likelihood of secondary cancers as a result of external beam therapy. I also believe that as the availability of Proton beam therapy increases so will the number of patients, the reason not many cancers qualify clinically is because of the cost of sending patients overseas, if consultants can treat their patients in the UK and near to their homes at a fraction of the cost then clinical indications for proton therapy will naturally increase. It is exactly this that the LIGHT system promises to provide... in this respect it is a game changer.